Plumb Emily V, Ham Rachel E, Napolitano Justin M, King Kylie L, Swann Theodore J, Kalbaugh Corey A, Rennert Lior, Dean Delphine
Research and Education in Disease Diagnosis and Intervention (REDDI) Lab, Center for Innovative Medical Devices and Sensors, Clemson University, Clemson, SC, United States.
Department of Bioengineering, Clemson University, Clemson, SC, United States.
Front Public Health. 2022 Apr 5;10:858421. doi: 10.3389/fpubh.2022.858421. eCollection 2022.
By developing a partnership amongst a public university lab, local city government officials and community healthcare providers, we established a drive-through COVID-19 testing site aiming to improve access to SARS-CoV-2 testing in rural Upstate South Carolina. We collected information on symptoms and known exposures of individuals seeking testing to determine the number of pre- or asymptomatic individuals. We completed 71,102 SARS-CoV-2 tests in the community between December 2020-December 2021 and reported 91.49% of results within 24 h. We successfully identified 5,244 positive tests; 73.36% of these tests originated from individuals who did not report symptoms. Finally, we identified high transmission levels during two major surges and compared test positivity rates of the local and regional communities. Importantly, the local community had significantly lower test positivity rates than the regional community throughout 2021 ( < 0.001). While both communities reached peak case load and test positivity near the same time, the local community returned to moderate transmission as indicated by positivity 4 weeks before the regional community. Our university lab facilitated easy testing with fast turnaround times, which encouraged voluntary testing and helped identify a large number of non-symptomatic cases. Finding the balance of simplicity, accessibility, and community trust was vital to the success of our widespread community testing program for SARS-CoV-2.
通过在一所公立大学实验室、当地市政府官员和社区医疗服务提供者之间建立合作伙伴关系,我们设立了一个免下车新冠病毒检测点,旨在改善南卡罗来纳州上州农村地区获得新冠病毒检测的机会。我们收集了寻求检测者的症状和已知接触情况信息,以确定有症状前或无症状个体的数量。在2020年12月至2021年12月期间,我们在社区完成了71102次新冠病毒检测,并在24小时内报告了91.49%的检测结果。我们成功识别出5244次阳性检测;其中73.36%的检测来自没有报告症状的个体。最后,我们在两次主要疫情激增期间确定了高传播水平,并比较了当地和区域社区的检测阳性率。重要的是,在整个2021年,当地社区的检测阳性率显著低于区域社区(<0.001)。虽然两个社区的病例数峰值和检测阳性率几乎同时出现,但当地社区在区域社区之前4周就恢复到了以阳性率表示的中度传播水平。我们的大学实验室实现了便捷检测且周转时间快,这鼓励了自愿检测,并帮助识别出大量无症状病例。找到简单性、可及性和社区信任之间的平衡对于我们广泛的新冠病毒社区检测项目的成功至关重要。